Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perfluoropropane-albumin Microspheres for Thyroid CEUS – Phase II Dose-finding
CTR20241007Phase 2Completed
- Sponsor
- Lizhuo Pharmaceutical (Xiamen) Co., Ltd.
- Start
- Mar 2024
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of perfluoropropane-albumin microspheres in thyroid nodule, sponsored by Lizhuo Pharmaceutical (Xiamen) Co., Ltd.. Started Mar 2024; status: completed.
02
Drugs
perfluoropropane-albumin microspheres
03
Conditions
thyroid nodule
Beyond the preview
Go deeper on CTR20241007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241007.